Cargando…
Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation
MSCs have been demonstrated to have a great benefit for type 1 diabetes mellitus (T1DM) due to their strong immunosuppressive and regenerative capacity. However, the comprehensive mechanism is still unclear. Our previous study indicated that transforming growth factor beta induced (TGFBI) is highly...
Autores principales: | Wu, Chushan, Liu, Weijiang, Liu, Yuanlin, Xu, Tingting, Li, Man, Li, Xue, Wang, Yang, Meng, Guangyu, Li, Lu, Zheng, Rongxiu, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110644/ https://www.ncbi.nlm.nih.gov/pubmed/36841925 http://dx.doi.org/10.1007/s13577-023-00868-9 |
Ejemplares similares
-
Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2
por: Zhou, Na, et al.
Publicado: (2021) -
Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis
por: Feng, Huan, et al.
Publicado: (2022) -
Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells
por: Liu, Weijiang, et al.
Publicado: (2021) -
Preliminary research on the effects and mechanisms of umbilical cord-derived mesenchymal stem cells in streptozotocin-induced diabetic retinopathy
por: Zhao, Ken, et al.
Publicado: (2020) -
Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
por: Tsai, Pei-Jiun, et al.
Publicado: (2012)